Share on LinkedInShare on LinkedIn

ARTICLE · 02 OCTOBER 2006

Now You See It, Now You Don’t—Infringement By An Intermediate

Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP
Contributor
Blake, Cassels & Graydon LLP

Blake, Cassels & Graydon LLP

As one of Canada’s top business law firms, Blake, Cassels & Graydon LLP (Blakes) provides...

View firm profile
Explore more from Blake, Cassels & Graydon LLP

The recent case of Abbott Laboratories v. Minister of Health and Ratiopharm addressed two notable issues, namely: (i) whether a patent is infringed by the production of a patented compound during an intermediate stage of the manufacture of a drug where the patented compound is not present in the finished drug; and (ii) whether a patent is invalid for anticipation in circumstances where the patented substance was previously made in the course of manufacturing another compound and the patented sub

CanadaIntellectual Property

Article by Lee Morrisroe, © 2006, Blake, Cassels & Graydon LLP

Originally published in Blakes Bulletin in Intellectual Property - Special Patent Issue, September 2006.

The recent case of Abbott Laboratories v. Minister of Health and Ratiopharm addressed two notable issues, namely: (i) whether a patent is infringed by the production of a patented compound during an intermediate stage of the manufacture of a drug where the patented compound is not present in the finished drug; and (ii) whether a patent is invalid for anticipation in circumstances where the patented substance was previously made in the course of manufacturing another compound and the patented substance was not known or stabilized prior to the patentee’s invention.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from